Objective Prospective evaluation of intestinal ultrasound (IUS) for disease monitoring of
patients with ulcerative colitis (UC) in routine medical practice. Design TRansabdominal …

This article reports on the sixth scientific workshop of the European Crohn's and Colitis
Organisation [ECCO] on the pathogenesis of extraintestinal manifestations [EIMs] in …

Background Knowledge of the real-world effectiveness and safety of tofacitinib for ulcerative
colitis (UC) is relevant to confirm the benefit observed in clinical trials. Methods This …

Guidelines for clinical practice are intended to suggest preferable approaches to particular
medical problems as established by interpretation and collation of scientifically valid …

Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

Background And Aims Endoscopic disease activity scoring in ulcerative colitis (UC) is useful
in clinical practice but done infrequently. It is required in clinical trials, where it is expensive …

Ulcerative colitis (UC) is a relapsing and remitting inflammatory disease of the colon with a
variable course. Despite advances in treatment, only approximately 40% of patients achieve …

Fecal calprotectin (FC) has emerged as one of the most useful tools for clinical management
of inflammatory bowel diseases (IBD). Many different methods of assessment have been …

Therapeutic advances in the management of IBD have led to a paradigm shift in the
assessment of IBD disease activity. Beyond clinical remission, objective assessment of …

Background: Mucosal healing (MH) was proposed to be an ideal treatment goal for patients
with inflammatory bowel disease (IBD). Instead of endoscopy to confirm MH, biomarkers are …